Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Grant program to support preclinical, PDX advancements
January 2018
SHARING OPTIONS:

SANTA CLARA, Calif.—A new grant program is underway thanks to Crown Bioscience, which launched the initiative to support oncology research scientists by providing funding to projects with potential to advance patient-derived xenograft (PDX) technology. The program will award research grants of up to $50,000 to projects that will accelerate preclinical innovation and novel PDX methodologies that improve clinical predictions. Proposals will be reviewed and selected by CrownBio’s Scientific Steering Committee.
 
“Crown Biosciences recognizes the importance of supporting investigators in early discovery,” said Laurie Heilmann, chief business officer at Crown Bioscience. “By investing in the brightest scientific minds, we can evolve the current research paradigms and establish novel tools that will help researchers and drug developers address global health challenges.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.